Focusing on Pharmaceutical Product Safety, InnoPack China Helps to Build a “Firewall”

With the gradual recovery of the global economy, the industry upgrading, reconstruction brought by the development of science and technology, enterprises focusing on drug quality, safety and effectiveness are fitting into broader, fairer and more favorable development environment. As a flagship exhibition for pharmaceutical packaging and drug delivery system industry in Asian-Pacific region, InnoPack China 2017 will once again open its gates on June 20-22, 2017 in Shanghai New International Expo Center. Together with domestic and international leading pharma packaging entreprises the show will offer pharmaceutical manufacturers a series of quality and innovative products and integrated solutions.

Raise automation and knowledge of packaging line, reduce package pollution risk of the product 

Many of the Chinese small medium-sized pharmaceutical factories keep using manual operation which not only fail to guarantee the packaging unity and stability, but also result in the risk of package pollution. It is without doubt that the automatic and intelligent drug packaging machinery will become a reform focus in the future reconstruction of pharmaceutical factories, with the advancement of GMP certification review and the pharmaceutical manufacturing enterprises’ demand for significant improvement of productivity. Represented by Multisorb, KYP, SKY, Omori Changkong, Double-Crane and Chunguang, and etc., a number of world famous pharmaceutical product packaging equipment enterprises has obtained brilliant achievements on the road of automation and intelligence, and have confirmed their participation in the exhibition in 2017 with their advantageous products.

Focus on upgrade of drug packaging materials and pharmaceutical excipients, consolidate the basis of drug safety

With the implementation of CFDA’s system of Associated Review and Approval of Pharmaceutical Packaging Materials, Pharmaceutical Excipients and Drugs, the subject responsibilities of preparation enterprises in the market are further defined, and higher requirements for packaging material quality, technology, process and risk control, etc. are raised by pharmaceutical manufacturers. Domestic and international leading enterprises in pharmaceutical packaging materials and excipients industry, such as SANNER, Bormioli, RENOLIT, Global Printing, Linuo, Ningbo Zhengli, Yiqing Medicinal Capsules, and Sichuan Helee, have all confirmed their participation at InnoPack China with their brand-new products and will aim to meet the new challenges as well as grasp the unprecedented opportunities of the industry in cooperation with InnoPack China 2017.

Optimization of drug delivery system and accessories design, improve patients’ drug use safety and effectiveness

As an important component of pharmaceutical industry, drug delivery system and accessories play a vital role in promoting the launch of products, ensure drug safety and effectiveness as well as patients’ drug compliance. They are now attracting more and more concern and attention from pharmaceutical enterprises and medical institutions worldwide. Experts represented by SCHOTT, OMPI, SGD, Nipro, West, Aptar, YPSOMED, H&T Presspart, Hoffmann Neopac, Nemera, Shandong Wego, Gerresheimer Shuangfeng, Shandong Pharmaceutical Glass, Cangzhou Four Stars, Hubei Huaqiang, and Linuo Glass, etc. will gather at 2017 InnoPack China to display, educate and lead the industry.

China Innopack news


Combining the vision of the global value chain and current development situation of the world’s pharma market, InnoPack China will bring a practical and  forward-looking industry feast for packaging equipment and material enterprises as well as pharmaceutical manufacturers. We also welcome your participation in promoting the development of the pharmaceutical packaging industry together!

Want to book a stand at Innopack 2018 in Shanghai? Click here. If you want to register as a visitor, click here.

For more information, please visit:, or contact Ms. Tina Zheng ([email protected]).